148 related articles for article (PubMed ID: 28443459)
1. Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6.
Dai PC; Liu DL; Zhang L; Ye J; Wang Q; Zhang HW; Lin XH; Lai GX
Tumour Biol; 2017 Apr; 39(4):1010428317697555. PubMed ID: 28443459
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3.
He CS; Liu YC; Xu ZP; Dai PC; Chen XW; Jin DH
Cell Physiol Biochem; 2016; 40(5):1221-1229. PubMed ID: 27960166
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
Hu T; Fei Z; Wei N
Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitro.
Shang L; Qu Z; Sun L; Wang Y; Liu F; Wang S; Gao H; Jiang F
J Pharm Pharmacol; 2011 May; 63(5):688-94. PubMed ID: 21492171
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer.
Liu W; Ning J; Li C; Hu J; Meng Q; Lu H; Cai L
Tumour Biol; 2016 May; 37(5):6331-6. PubMed ID: 26628299
[TBL] [Abstract][Full Text] [Related]
6. Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines.
Nishimura Y; Takiguchi S; Yoshioka K; Nakabeppu Y; Itoh K
Int J Oncol; 2012 Oct; 41(4):1520-30. PubMed ID: 22859339
[TBL] [Abstract][Full Text] [Related]
7. The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues.
Chang YX; Sun YG; Li J; Zhang QH; Guo XR; Zhang BL; Jin H; Gao XM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():71-5. PubMed ID: 23217309
[TBL] [Abstract][Full Text] [Related]
8. [Amic solution hydrolysis for improving content of astragaloside IV in extract of Radix Astragali].
Liu M; Zhou J; Zhang QW; Liu F
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):635-8. PubMed ID: 18590188
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum Ca-ATPase.
Xu XL; Chen XJ; Ji H; Li P; Bian YY; Yang D; Xu JD; Bian ZP; Zhang JN
Pharmacology; 2008; 81(4):325-32. PubMed ID: 18349554
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.
Duan Q; Pang C; Chang N; Zhang J; Liu W
Oncol Rep; 2016 Jul; 36(1):551-8. PubMed ID: 27176594
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbal medicine Fuzheng Kang-Ai decoction sensitized the effect of gefitinib on inhibition of human lung cancer cells through inactivating PI3-K/Akt -mediated suppressing MUC1 expression.
Li L; Wang S; Zheng F; Wu W; Hann SS
J Ethnopharmacol; 2016 Dec; 194():918-929. PubMed ID: 27989877
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines].
Deng Y; Chen HF
Zhong Xi Yi Jie He Xue Bao; 2009 Dec; 7(12):1174-80. PubMed ID: 20015441
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer.
Han Z; Liu L; Liu Y; Li S
Int J Clin Exp Pathol; 2014; 7(8):4774-81. PubMed ID: 25197348
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats.
Song J; Zheng SR; Jin Y; Li J
Planta Med; 2014 Feb; 80(2-3):187-92. PubMed ID: 24452462
[TBL] [Abstract][Full Text] [Related]
18. Ophiopogonin B induces apoptosis, mitotic catastrophe and autophagy in A549 cells.
Chen M; Guo Y; Zhao R; Wang X; Jiang M; Fu H; Zhang X
Int J Oncol; 2016 Jul; 49(1):316-24. PubMed ID: 27175570
[TBL] [Abstract][Full Text] [Related]
19. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
